Concepedia

Christopher M. Browne

CM

10

Publications

579

Citations

10

H-Index

2012

Active since

Affiliations

Harvard University(Current)

Brigham and Women's Hospital

Dana-Farber Cancer Institute

Cornell University

Saarland University

Christopher M. Browne is an author at Harvard University specializing in medicine, pharmacology, and natural sciences.

Top concepts

MedicinePharmacologyProteomicsDrug DiscoveryNatural SciencesBiochemistryMolecular BiologySystems BiologyMass SpectrometryBioinformatics

Publications per year

2012–2021

10

Publications

10

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

Christian Dubiella, Benika J. Pinch, Kazuhiro Koikawa et al. · Nature Chemical Biology · 2021 · 141 citations · Full text

Covalent Inhibitor, Oncology, Malignant Disease +9

A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification

Christopher M. Browne, Baishan Jiang, Scott B. Ficarro et al. · Journal of the American Chemical Society · 2018 · 89 citations · Full text

Drug Target, Chemoproteomic Strategy, Enrichment Reagents +16

Identification of a potent and selective covalent Pin1 inhibitor

Benika J. Pinch, Zainab M. Doctor, Behnam Nabet et al. · Nature Chemical Biology · 2020 · 83 citations · Full text

Molecular Docking, Medicinal Chemistry, Drug Target +4

Leveraging Compound Promiscuity to Identify Targetable Cysteines within the Kinome

Suman Rao, Deepak Gurbani, Guangyan Du et al. · Cell chemical biology · 2019 · 65 citations · Full text

Protein Function, Compound Promiscuity, Structural Bioinformatics +11

Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors

Sindhu Carmen Sivakumaren, Hyeseok Shim, Tinghu Zhang et al. · Cell chemical biology · 2020 · 53 citations · Full text

Drug Targeting, Drug Target, Receptor Tyrosine Kinase +5

Rows per page

1–5 of 10